Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Filter Results

1269 News Releases Found

Pheo Para Alliance, has designated Dana-Farber Cancer Institute/Brigham and Women’s Hospital as a Pheo Para Clinical Center
News Releases
6/27/2022

Dana-Farber Cancer Institute/Brigham and Women’s Hospital Designated as Rare Disease Clinical Center for Pheochromocytoma & Paraganglioma

  • Research
  • Neuroendocrine/Carcinoid Tumors
Sara M. Tolaney, MD, MPH
News Releases
6/23/2022

Study finds breast cancers with low levels of HER2 protein are not a distinct subtype of the disease  

  • Breast Cancer
Katherine A. Janeway, MD, MMSc
News Releases
6/23/2022

Study Shows That Genomic Tumor Profiling of Pediatric Tumors Can Enhance Clinical Care

  • Precision Cancer Medicine
  • Cancer Genetics, Childhood
_
News Releases
6/22/2022

Dana-Farber Cancer Institute receives a grant from the Richard K. Lubin Family Foundation to establish the Lubin Family Foundation Scholar Awards

  • Research
Laurie H. Glimcher, MD
News Releases
6/18/2022

Laurie H. Glimcher, MD named to Modern Healthcare’s 50 Most Influential Clinical Executives Class of 2022

_
News Releases
6/15/2022

Cancer clinical trials bounce back after significant COVID-19 disruption: data from two large US cancer centers

  • Research
_
News Releases
6/14/2022

Dana-Farber/Boston Children's again named top pediatric cancer program

  • Blood Disorders, Childhood
Toni Choueiri, MD
News Releases
6/7/2022

Dana-Farber Cancer Institute, Gustave Roussy, and L’Institut Servier sign an oncology cooperation agreement

Paul G. Richardson, MD
News Releases
6/5/2022

Improved progression-free survival in patients with multiple myeloma following three-drug therapy with autologous stem cell transplant

  • Research
  • Multiple Myeloma